Solid Biosciences Inc. (SLDB)
- Sector
- Biotechnology
- Last price
- $6.48
- As of
Kresmion compiles this page from SLDB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Solid Biosciences Inc. (SLDB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-04.
See the full SLDB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SLDB on one page. Preview it with sample data, then open it live with a free account.
Preview the SLDB dossierActive events for SLDB
- mediumEarnings above estimates
Q3-2026: Beat consensus by 14.8%, EPS $-0.36 vs $-0.4227 estimate
- high13F: large reduction
CITADEL ADVISORS LLC cut 74% of SLDB (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +2242% to SLDB (2026Q2)
- high13F: large reduction
Point72 Asset Management, L.P. cut 78% of SLDB (2026Q2)
- high13F: large increase
D. E. Shaw & Co., Inc. added +74% to SLDB (2026Q2)
FREE, NO ACCOUNT
Every event on SLDB, as it fires
You are seeing 5 of 6 events recorded on SLDB since 2026-08-11.
The five above landed across 2 days. The other 1 were recorded on 1 other days. 4 of the 6 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, SLDB
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on SLDB
SLDB against its peers
SLDB's return on equity of -96.8% ranks in the 32nd percentile of 19 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | SLDB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 83.3M | n/a | 12 |
| Operating margin | n/a | -114.2% | n/a | 12 |
| Net margin | n/a | -120.7% | n/a | 12 |
| Return on equity | -96.8% | -45.8% | 33 | 19 |
| 1 year | 44.6% | -3.8% | 83 | 20 |
Peers (21): ANNX, PRME, LXRX, ARDX, JANX, GLUE, IRWD, SGMT, XOMA.D, SNDX, SANA, RIGL, NVCT, ACHV, MGTX, DBVT, AVBP, FDMT, OLMA, CRVS, ORIC. Left out: OBX (no annual filing), LTGO (no annual filing), ATTO (no annual filing), BBTX (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (SLDB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in SLDB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SLDB in the last 180 days.
Upstream: SEC EDGAR filings for SLDB
Kresmion, "Solid Biosciences Inc. (SLDB) institutional holdings and SEC filings", data as of 2026-11-12, https://kresmion.com/research/SLDB. Upstream data: SEC EDGAR filings for SLDB.
Link to this data (HTML):
<a href="https://kresmion.com/research/SLDB">Solid Biosciences Inc. (SLDB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow SLDB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SLDB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.